Back to trial
Eligibility Pre-Screening
Efficacy and Safety of DKF-MA102 in Patients With Prostate Cancer
This is a simplified pre-screening tool. Your answers help estimate whether you might qualify, but only the research team can confirm your eligibility. This is not medical advice.
Question 1 of 70%